Over the latest trailing 12-month period, total return cagr is +84.99%. The comparable SPY value is +16.26%. Year-to-date total return is +110.27%. Total return includes price appreciation and reinvested dividends.
Over the past 12 months, Total Return CAGR is 84.99%. Total return includes dividends reinvested. The total return CAGR includes both price appreciation and dividends reinvested. This gives a more complete picture of the company's investment performance.
Hinge Health, Inc. (HNGE)
Total Return growth vs the same calendar quarter one year earlier, last 3 comparable quarters.
Quarter-end value of $100 invested at the start of the available history, with dividends reinvested; the newest quarter may be quarter-to-date. Q4 2026 (2026-10-02): $260.04.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-05T10:50:31.056Z. Historical observations retain their original dates. Historical series through 2026-10-02.
Unrounded diluted TTM EPS / FMP quote price × 100 Quote observation: 2026-10-05T10:50:31.056Z. Historical observations retain their original dates. Historical series through 2026-10-02.
| Year | Total return for the year |
|---|---|
| 2026 (YTD) | +110.27% |
| Period | Period End | QoQ Return | YoY Return |
|---|---|---|---|
| Q4 2026 (QTD) | 2026-10-02 | +0.4% | +110.3% |
| Q3 2026 | 2026-09-30 | +17.2% | +98.1% |
| Q2 2026 | 2026-06-30 | +115.2% | +60.4% |
| Q1 2026 | 2026-03-31 | -17.0% | N/A |
| Q4 2025 | 2025-12-31 | -5.4% | N/A |
| Q3 2025 | 2025-09-30 | -5.2% | N/A |
| Q2 2025 | 2025-06-30 | N/A | N/A |
Calendar returns: QoQ compares the prior calendar quarter; YoY compares the same calendar quarter a year earlier. The newest quarter is in progress (quarter-to-date).
